AUS
NZ
UK
CA
USA
IND
Highlights
- Oxford Nanopore Technologies Ltd develops sequencing platforms for real-time molecular analysis.
- The company offers scalable systems for use in research, diagnostics, and scientific exploration.
- It is part of the FTSE 250 Companies, positioned among notable science-led UK-listed firms.
Oxford Nanopore Technologies Ltd (LSE:ONT) operates in the life sciences and biotechnology space. The company creates real-time DNA and RNA sequencing tools designed for use across academic, clinical, and field research environments. As part of the FTSE 250 Companies, it contributes to a growing network of technology-focused businesses offering molecular-level data through portable and scalable systems. The business model reflects a dedication to simplified and flexible access to genomics across different user profiles.
Core Technology and Platform Features
The company’s main offering is its nanopore-based sequencing platform, which allows for direct reading of nucleic acid sequences in real time. This platform includes handheld devices designed for rapid deployment and larger, high-capacity systems for laboratory use.
Use cases span from public health to biodiversity monitoring, enabling users to analyse genetic data with minimal infrastructure. The platform delivers continuous data streams, supporting real-time access during sequencing.
Deployment Versatility and Product Structure
Oxford Nanopore’s product range supports various throughput needs, providing options for low-scale, field-based research as well as high-volume institutional sequencing. Devices are paired with software platforms that enable real-time tracking and analysis.
This flexibility makes the technology applicable to a wide range of sectors, including healthcare, environmental research, industrial process monitoring, and food safety systems.
Operational Structure and Capabilities
The company’s operations span research, development, manufacturing, and support services. Its technology integrates sequencing hardware with cloud-enabled software to create end-to-end genomic solutions. This approach simplifies user workflows and reduces time to results.
Operational activities focus on expanding the reach of its tools through distribution networks and research partnerships, promoting greater accessibility to DNA and RNA sequencing globally.
Role Among FTSE 250 Companies
Oxford Nanopore Technologies Ltd is ranked among FTSE 250 Companies, a group representing mid-sized listed businesses across various sectors in the UK market. The company stands out for its role in scientific instrumentation and real-time molecular data systems.
Its position within the index is supported by its capacity to deliver specialised platforms that address key needs in diagnostics, applied sciences, and advanced research applications.
What sector does Oxford Nanopore Technologies Ltd operate in?
Oxford Nanopore operates in the biotechnology and life sciences sector.
What does the company produce?
It produces real-time DNA and RNA sequencing platforms for diverse use cases.
Is Oxford Nanopore part of any UK index?
Yes, Oxford Nanopore Technologies Ltd is part of the FTSE 250 Companies.
